Skip to main content

Table 1 Quality and characteristics of included studies

From: Meta-analysis of surgical resection and radiofrequency ablation for early hepatocellular carcinoma

Reference

Date

Design

Jadad score

Treatment

Number of patients

Sex (M/F)

Mean age (years)

Tumor number (single/multiple)

Mean tumor size (cm)

Nishikawa

2011

NRCT

1

SR

69

50/19

67.4 ± 9.7

69/0

2.68 ± 0.49

    

RFA

162

95/67

68.4 ± 8.7

162/0

1.99 ± 0.62

Tashiro

2011

NRCT

1

SR

199

137/62

65.7 ± 9.0

132/67

2.1 ± 0.63

    

RFA

87

53/34

66.3 ± 8.2

67/20

1.8 ± 0.52

HUNG

2011

NRCT

1

SR

229

184/45

60.07 ± 12.56

181/48

2.88 ± 1.06

    

RFA

190

121/69

67.42 ± 11.45

152/38

2.37 ± 0.92

Nanashima

2010

NRCT

1

SR

144

112/32

63.6 ± 8.8

128/16

NA

    

RFA

56

36/20

67.7 ± 8.5

51/5

NA

Huang

2010

RCT

4

SR

115

85/30

55.91 ± 12.68

89/26

NA

    

RFA

115

79/36

56.57 ± 14.30

84/31

NA

Ueno

2009

NRCT

1

SR

123

82/41

67 (28 to 85)

110/13

2.7 ± 0.1

    

RFA

155

100/55

66 (40 to 79)

101/54

2.0 ± 0.1

Guglielmi

2008

NRCT

1

SR

91

73/18

NA

69/22

NA

    

RFA

109

88/21

NA

65/44

NA

Hiraoka

2008

NRCT

1

SR

59

44/15

62.4 ± 10.6

NA

22.7 ± 5.5

    

RFA

105

76/29

69.4 ± 9.1

NA

19.8 ± 5.2

Abu-Hilal

2008

NRCT

3

SR

34

26/8

67

NA

3.8 (1.3 to 5)

    

RFA

34

27/7

65

NA

3 (2 to 5)

Takahashi

2007

NRCT

1

SR

53

39/14

66 (41 to 80)

41/12

2.5 (1 to 5)

    

RFA

171

120/51

69 (44 to 84)

124/47

2.1 (0.7 to 4.8)

Chen

2006

RCT

4

SR

90

75/15

49.4 ± 10.9

NA

NA

    

RFA

71

56/15

51.9 ± 11.2

NA

NA

Hong

2005

NRCT

1

SR

93

69/24

49.2 ± 9.9

NA

2.5 ± 0.8

    

RFA

55

41/14

59.1 ± 9.6

NA

2.4 ± 0.6

Vivarell

2004

NRCT

2

SR

79

57/22

65.2 ± 8.2

66/13

NA

    

RFA

79

67/12

67.8 ± 8.7

46/33

NA

  1. NA: Not available; NRCT: non-randomized controlled trial; RCT: randomized controlled trial; RFA: radiofrequency ablation; SR: surgical resection.